{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"To evaluate progression free survival (PFS) and in patients with multiple myeloma undergoing autologous stem cell transplant using the combination of high dose melphalan and total marrow irradiation.","groups":[{"description":"Cohort 1 patients will receive standard high dose melphalan with autologous stem cell rescue. Plus TMI at a dose of 3Gy.","id":"OG000","title":"Cohort 1 TMI Dose 3Gy"}],"populationDescription":"Data not collected","reportingStatus":"POSTED","timeFrame":"Up to 1 year post-transplant.","title":"Progression Free Survival No Results Due to 1 Subject Came Off Treatment Within 7 Days and 1 Subject Came Off Treatment Within 5 Days. Not Enough Data to Analyze","type":"PRIMARY"}